1. Field of the Invention
This invention relates in general to biochemical assays. More specifically, but without restriction to the particular embodiments hereinafter described in accordance with the best mode of practice, the present invention relates to methods and apparatus for chromatography based immunochemical assays performed on optical bio-discs and related detection systems.
2. Description of the Related Art
The detection and quantification of analytes in the blood or other body fluids are essential for diagnosis of diseases, elucidation of the pathogenesis, and for monitoring the response to drug treatment. Traditionally, diagnostic assays are performed in laboratories by trained technicians using complex apparatus. Performing these assays is usually time-consuming and costly. Thus, there is a significant need to make diagnostic assays and forensic assays of all types faster and more local to the end-user. Ideally, clinicians, patients, investigators, the military, other health care personnel, and consumers should be able to test themselves for the presence of certain risk factors or disease indicators in their systems, and to test for the presence of certain biological material at a crime scene or on a battlefield. At present, there are a number of medical diagnostic, silicon-based, devices with nucleic acids and/or proteins attached thereto that are commercially available or under development. These chips are not for use by the end-user, or for use by persons or entities lacking very specialized expertise and expensive equipment.
Commonly assigned U.S. Pat. No. 6,030,581 entitled “Laboratory in a Disk” issued Feb. 29, 2000 (the '581 patent) is hereby incorporated by reference in its entirety. The '581 patent discloses an apparatus that includes an optical disc, adapted to be read by an optical reader, which has a sector having a substantially self-contained assay system useful for localizing and detecting an analyte suspected of being in a sample. U.S. Pat. No. 5,993,665, issued Nov. 30, 1999 (the '665 patent) entitled “Quantitative Cell Analysis Methods Employing Magnetic Separation” discloses analysis of biological specimens in a fluid medium where the specimens are rendered magnetically responsive by immuno-specific binding with ferromagnetic colloid. The '665 patent is hereby incorporated by reference in its entirety.
The present invention relates to performing chromatography, including for example, affinity, size exclusion, reverse phase, and ion exchange. Ion exchange chromatography may include anion exchange, cation exchange, cation exchange linked immunoassays (CELIA), and anion exchange linked immunoassays, in conjunction with colorimetric and/or fluorescent detection and quantitation using an optical analysis disc or optical bio-disc. The invention includes methods for preparing assays, methods for depositing the reagents required for the assays, discs for performing assays, and detection systems.
High pressure liquid chromatography (HPLC) and other types of chromatography is generally used to separate substances or analytes of interest having different physical properties and quantitate these analytes using UV/VIS, IR, luminescence, or fluorescence detection. Chromatographic instruments generally require costly equipment and maintenance and trained personnel to carry out complicated time-consuming tests. It is an object of the present invention to make possible a simple chromatography system for testing analytes, portable and for use by the end user.
The present invention includes methods for isolating and quantifying the concentration of an analyte of interest in a biological sample on optical bio-discs using calorimetric or fluorometric detection. Analytes may include, for example, Hemoglobin, glycated and non-glycated hemoglobin, and other isoforms of proteins. All reagents necessary for the assays may be immobilized on the optical disc prior to the assay. To perform the assay, the sample (preferably serum, but other types of body fluids could also be used) is loaded into the channel via the injection port. After injection, the port is sealed, the disc is spun, and the sample is moved through one or more micro-chromatographic matrices, by centrifugation, comprising different separation media including, for example, size exclusion and ion exchange matrices. The matrix may be formed from resins or beads, gels, or membranes. Once the analyte of interest is separated chromatographically, the analyte solution, containing the analyte of interest is then directed into an analysis chamber. The analysis chamber may contain detection reagents including, but not limited to, capture agents bound to the surface of a capture zone and signal antibodies conjugated with one or more reporters, both of which have affinity to different epitopes on the same analyte of interest. Reporters may include, but are not limited to, fluorophores, luminophores, microspheres, enzymes, and nanospheres. The analyte is incubated in the analysis chamber at a pre-determined temperature and time to allow sufficient binding of the analyte to the capture agent and binding of the signal antibodies to the analyte. After incubation the analysis chamber is washed to remove unbound signal antibodies and analytes. If the reporter used in the assay is a non-enzyme detectable reporter such as beads, then the analysis chamber may then be analysed for presence and amount of reporter beads using the disc reader. Otherwise, if an enzyme reporter is used, an enzyme substrate is added to the analysis chamber. The enzyme is allowed to catalize an enzyme-substrate reaction that produces a detectable signal such as color or fluorescence. The optical disc reader then quantifies the intensity of the color of fluorescence developed. After approximately 3 minutes of data collection and processing, the results of the assay are displayed on a computer monitor. Alternatively, an inherent enzymatic activity of the analyte itself may be advantageously used to produce a detectable signal. A non-limiting example of such an analyte is hemoglobin that has an inherent peroxidase activity. Thus capture and signal agents are not necessary with this method thereby allowing a one step assay method without the need for washing steps. In this method, the sample is loaded into the disc, ran through the matrix, and into the analysis chamber, as described above. The analysis chamber, in this method, would only contain the appropriate substrate, a peroxidase substrate like ABTS (2,2′-azino-di-[3-ethyl-benzthiazoline] sulfonic acid) may be used in conjunction with the hemoglobin analyte, for example. Once the signal is generated, the disc is then analyzed using the optical disc reader, as described above.
It should be noted that most diagnostic calorimetric assays in clinical laboratories are carried out at 37 degrees Celsius to facilitate and accelerate color development. For ease of operation, colorimetric assays performed on optical discs are optimized to run at ambient temperature. The optimization includes selection of enzyme sources, enzymes concentrations, and sample preparation.
Chromagen selection, in the calorimetric aspect of the present invention, is of critical importance in optimizing colorimetric assays for optical density measurements on bio-discs since chromagens need to be detected at specific wavelengths. CD-R type disc readers, for example, require chromagens that can be detected in the infrared region (750 nm to 800 nm). Other types of optical disc systems may be used in the present invention including DVD, DVD-R, fluorescent, phosphorescent, and any other similar optical disc reader. The amplitude of optical density measurements depends on the optical path length, the molar extinction coefficient of the chromagen and the concentration of the analyte of interest (Beer's law). To optimize the sensitivity of calorimetric assays on optical discs, several chromagens with high molar extinction coefficients at the wavelengths of interest have been identified and evaluated.
Chromagens suitable for colorimetric assays on CD-R type optical discs include, but are not limited to, N,N′-Bis(2-hydroxy-3-sulfopropyl) tolidine, disodium salt (SAT-3), N-(Carboxymethylaminocarbonyl)-4,4′-bis(dimethylamino)
According to one aspect of the present invention, there are provided detection methods for quantifying the concentration of an analyte of interest in a biological sample on the bio-discs. The detection includes directing a beam of electromagnetic energy from a disc drive toward the capture field and analyzing electromagnetic energy returned from or transmitted through the capture field.
The optical density change, in the colorimetric assay aspect of the present invention, may be quantified by the optical disc reader by two related ways. These include measuring the change in light either reflected or transmitted. The disc may be referred to as reflective, transmissive, or some combination of reflective and transmissive. In a reflective disc, an incident light beam is focused onto the disc (typically at a reflective surface where information is encoded), reflected, and returned through optical elements to a detector on the same side of the disc as the light source. In a transmissive disc, light passes through the disc (or portions thereof) to a detector on the other side of the disc from the light source. In a transmissive portion of a disc, some light may also be reflected and detected as reflected light. Different detection systems are used for different types of bio-discs (top versus bottom detector).
The conversion of data captured by the CD reader into meaningful concentration units is mediated via data processing software specific for the assay of interest.
The apparatus and methods in embodiments of the present invention can be designed for use by an end-user, inexpensively, without specialized expertise and expensive equipment. The system can be made portable, and thus usable in remote locations where traditional diagnostic equipment may not generally be available.
Alternatively, fluorescent assays can be carried out to quantify the concentration of an analyte of interest in a biological sample on the optical discs. In this case, the energy source in the disc drive preferably has a wavelength controllable light source and a detector that is or can be made specific to a particular wavelength. In yet another alternative, a disc drive can be made with a specific light source and detector to produce a dedicated device, in which case the source may only need fine-tuning.
Analysis of biological fluids aimed at the quantitative and qualitative determination of substances associated with a wide variety of physiological disorders, bioresearch, proteomics, environmental studies, agriculture, and food industry, relies on specific binding assays from which the immunoassay plays a dominant role. The outstanding specificity and sensitivity for quantitative determination of an almost limitless number of analytes in practically any milieu, and the ability to miniaturize and adapt to automation makes them ideal tools for routine assays.
Antibody binding techniques are based on the interaction of a binding antibody, receptor, or other binding proteins with an antigen or a specific ligand molecule and the formation of an antibody-antigen or receptor-ligand complex. By changing certain conditions a binding assay can be designed to determine either an analyte, ligand, or target binding reagent or an antibody of interest. The steps are similar but the assay configuration provides results pertinent to the antigen or antibody of interest.
1. Capture Probe Binding and Sample Application
When a sample is injected into a micro-channel, fluidic circuit, or flow channel on an optical bio-disc, the target agent including, for example, target antigen or antibody, binds to a capture probe bound in a capture or target zone on a solid support such as a disc substrate. The capture probe may be an antigen recognized by the target antibody or an antibody or receptor with specific affinity to the target antigen or ligand. Following the binding step, unbound target agent is removed through a wash step. It should be understood that various techniques, procedures and chemistries, know in the art, may be used to bind the capture probe onto a solid support including, but not limited to, direct covalent binding of probes onto a metallic or activated surface, passive adsorption, and through cross-linking reagents.
Further details relating to surface chemistries used to bind probes onto solid support are disclosed in, for example, the above incorporated commonly assigned co-pending U.S. Provisional Application Ser. No. 60/353,770 entitled “Capture Layer Assemblies Including Metal Layer for Immobilization of Receptor Molecules and Related Optical Assay Discs” filed Jan. 30, 2002; and U.S. Provisional Application Ser. No. 60/353,745 entitled “Capture Layer Assemblies Including Polymer Substrates for Immobilization of Receptor Molecules and Related Optical Assay Discs” filed Jan. 30, 2002.
In addition to surface chemistries for attaching capture probes, blocking agents may be used to block areas within the capture or target zone and the flow channel where capture probes are not bound (non-capture areas) to prevent non-specific binding of the target or analyte, signal probes, and reporters onto these areas. Blocking agents include, but are not limited to proteins such as BSA, gelatin, sugars such as sucrose, detergents such as tween-20, genetic material such as sheared salmon sperm DNA, and polyvinyl alcohol.
2. Signal Generation
Signal is generated from tags or labels attached to signal or reporter agents or probes that have specific affinity to a target agent. Signal agents or probes may include, for example, signal antibodies or signal ligands, tagged with microspheres, sub-micron nanospheres, or enzymes. The microspheres or nanospheres may be fluorescent labeled (fluospheres), phosphorescent, luminecent, or chemiluminescent. The microspheres or nanospheres may also carry different chemical functionalities including, for example, carboxyl, amino, aldehyde, and hydrazine functional groups. These functional groups may facilitate binding of the signal agent. The enzyme may facilitate a chemical reaction that produces fluorescence, color, or a detectable signal in the presence of a suitable substrate. For example, conjugated horseradish peroxidase (HRP; Pierce, Rockford, Ill.) may be used with the substrate 3,3,5,5-tetramethylbenzidine (TMB; Calbiochem cat. no. 613548, CAS-54827-17-7) in the presence of hydrogen peroxide to produce an insoluble precipitate. Horseradish peroxidase can also be used in conjunction with CN/DAB (4-chloronaphthol/3,3′-diaminobenzidine, tetrahydrochloride), 4-CN (4-chloro-1-napthol), AEC (3-amino-9-ethyl carbazol) and DAB (3,3-diaminobenzidine tetrahydrochloride) to form insoluble precipitates. Similarly, the enzyme alkaline phosphatase (AP) can be used with the substrate bromochloroindolylphosphate in the practice of the present invention. Other suitable enzyme/substrate combinations will be apparent to those of skill in the art.
3. Detection
The signal from the microspheres or the enzyme reaction can be read with the optical bio-disc readers developed to be utilized in conjunction herewith. Either a bottom detector on a disc with a reflective cover, or a top detector with a transmissive disc may be employed as the optical bio-disc reader for the assay and disc inventions disclosed herein.
(a) Disc Implementation
The assays and methods of the present invention may be advantageously implemented on an analysis disc, modified optical disc, or bio-disc. The bio-disc may include a flow channel having target or capture zone, a return channel in fluid communication therewith, a mixing chamber in fluid communication with the flow channel, and in some embodiments a waste reservoir in fluid communication with the flow channel.
The bio-disc may be implemented on an optical disc including an information encoding format such as CD, CD-R, or DVD or a modified version thereof. The bio-disc may include encoded information for performing, controlling, and post-processing the test or assay. For example, such encoded information may be directed to controlling the rotation rate of the disc, incubation time, incubation temperature, and/or specific steps of the assay. Depending on the test, assay, or investigational protocol, the rotation rate may be variable with intervening or consecutive sessions of acceleration, constant speed, and deceleration. These sessions may be closely controlled both as to speed and time of rotation to provide, for example, mixing, agitation, or separation of fluids and suspensions with agents, reagents, DNA, RNA, antigen, antibodies, ligands, and receptors.
(b) Drive Implementation
A bio-disc drive assembly or reader may be employed to rotate the disc, read and process any encoded information stored on the disc, and analyze the samples in the flow channel of the bio-disc. The bio-disc drive is thus provided with a motor for rotating the bio-disc, a controller for controlling the rate of rotation of the disc, a processor for processing return signals from the disc, and an analyzer for analyzing the processed signals. The drive may include software specifically developed for performing the assays disclosed herein.
The rotation rate of the motor is controlled to achieve the desired rotation of the disc. The bio-disc drive assembly may also be utilized to write information to the bio-disc either before or after the test material in the flow channel and target or capture zone is interrogated by the read beam of the drive and analyzed by the analyzer. The bio-disc may include encoded information for controlling the rotation rate of the disc, providing processing information specific to the type of test to be conducted, and for displaying the results on a display monitor associated with the bio-drive in accordance with the assay methods relating hereto.
Further objects of the present invention together with additional features contributing thereto and advantages accruing therefrom will be apparent from the following description of the preferred embodiments of the invention which are shown in the accompanying drawing figures with like reference numerals indicating like components throughout, wherein:
The present invention relates in general to preparation of biomedical samples and analysis of same using an optical bio-disc system. More specifically, this invention is directed to performing chromatography, including for example, affinity, size exclusion, reverse phase, and ion exchange. Ion exchange chromatography may include anion exchange, cation exchange, cation exchange linked immunoassays (CELIA), and anion exchange linked immunoassays, in conjunction with calorimetric and/or fluorescent detection and quantitation using an optical analysis disc or optical bio-disc. The invention includes methods for preparing assays, methods for depositing the reagents required for the assays, discs for performing assays, and detection systems. Each of the aspects of the present invention is discussed below in further detail.
Drive System and Related Discs
The second element shown in
The third element illustrated in
Referring now to
The second element shown in
The third element illustrated in
In addition to Table 1,
With reference next to
With continuing reference to
The final principal structural layer in this transmissive embodiment of the present bio-disc 110 is the clear, non-reflective cap portion 116 that includes inlet ports 122 and vent ports 124.
Referring now to
As shown in
Alternative embodiments of the bio-disc according to the present invention will now be described with reference to
Furthermore, the following description of the bio-disc of the invention can be readily applied to a transmissive-type as well as to a reflective-type optical bio-disc described above in conjunction with FIGS. 2 to 9.
Detection of Hemoglobin and Glycohemoglobin Using the Optical Bio-Disc
Glycohemoglobin analysis is used in long-term carbohydrate control of diabetics. Glycohemoglobin is formed when glucose binds to hemoglobin (Hb) at the N-terminal valine on the beta-chain resulting in the formation of HbAlc. Antibody-based assays have been used to detect the non-enzymatic glycation of Hb directly. However, producing HbAlc specific antibodies in animals is very difficult since the sugar moiety of the glycohemoglobin molecule is not exposed and will rarely result in a specific immuneresponse. A combination of isocratic ion exchange chromatography with a class-specific immunoassay for hemoglobin can rapidly analyze glycated hemoglobin without the need of a specific probe for HbAlc. Different methods for glycohemoglobin analysis implemented on the optical bio-discs are described below.
Cation Exchange Linked Immunoassay (CELIA) on the Optical Bio-Disc Ion Exchange Resins
A sandwich immunoassay for hemoglobin was developed by immobilizing haptoglobin (a general capture agent for hemoglobin species) directly on the gold surface of an optical bio-disc substrate. Horseradish peroxidase (HRP)-labeled goat anti-human hemoglobin antibody was used as the enzyme conjugated signal antibody. ABTS (2,2′-azino-di-(3-ethyl-benzthiazoline sulfonic acid) was used as the enzyme substrate. Optical bio-disc derived images were taken and four-parameter-fitted standard curves were generated as shown in
Weak cation exchange resins (e.g., carboxymethyl Sephadex beads) may be used to separate non-glycated hemoglobin from glycated hemoglobin species in a test sample.
Fluorescent labels may be used instead of HRP-labeled anti human hemoglobin signal antibodies and the assay quantified using a fluorescent optical bio-disc drive. Furthermore the capture and signal agents may be haptoglobin instead of antibodies. In this case, the assay will consist of a haptoglobin capture agent immobilized on a capture or target zone within an analysis chamber and a HRP- or fluorescent labeled haptoglobin signal agent. Other detectable labels known in the art can also be applied. The pseudo-peroxidase activity of hemoglobin can also be used to produce a detectable signal with the appropriate peroxidase substrate and requires only the (unlabeled) haptoglobin capture agent (or other capture proteins for hemoglobin) to capture the analyte, as described above.
The ion exchange matrix may be packed into the fluidic channels and separated from the analysis chamber 202 by using a different channel and/or chamber thickness for the analysis chamber 202. For example, 40-120 micron cation exchange beads may be used to form the ion exchange matrix. Thus a channel or chamber on the disc with a thickness of >120 microns (“ion exchange zone”) connected to a second channel or chamber with a thickness of <40 microns (analysis chamber) can be used. The narrower thickness of the analysis chamber prevents the beads from entering the analysis chamber. Furthermore a microfluidic channel design with a capillary valve system can also be used in conjunction with the ion exchange linked immunoassay embodiments of the present invention.
Ion Exchange Membranes
1) Lateral Flow Membranes
In a sandwich assay format method of the present invention, the capture agent, which can be an antibody or haptoglobin or another capture protein for hemoglobin, may be labeled with reporter particles (latex beads, gold beads, carbon beads, or others). After sample application and disc spinning steps, non-glycated hemoglobin binds to the cation exchange matrix and glycated hemoglobin will move to the specific analysis chamber and to the target or capture zone. The target zone is then analyzed for the presence and amount of reporter particles using the optical bio-disc reader. For the measurement of non-glycated hemoglobin the ion exchange matrix may be formed from a weak anion exchange membrane.
2) Flow Through Membrane (Membrane Adsorbers)
Ion Exchange Membrane Adsorbers used in ready-to-use filters (Sartorius, Goettengen, Germany) may also be used to form the matrix. Furthermore, centrifuge based Ion Exchange Membrane Spin Columns such as for example Vivapure (Viva Science, Hannover, Germany) can also be embedded into an optical bio-disc and used for the separation of different isoforms of proteins (including various hemoglobin species) with subsequent, immunoassay-based optical bio-disc detection.
With reference to
Referring now to
Turning next to
Bioseparation with a porous membrane is of critical importance in molecular biology assays. The present application demonstrates fluidic channel arrangements for integration of porous materials, such as a porous membrane or a chromatographic membrane, into the optical bio-disc 110.
The bio-disc 110 is preferably made from several layers of polycarbonate discs and patterned adhesives to form a fluidic circuit. By integrating the porous membrane, the applied analyte will flow through the porous material when the analyte is driven by centrifugal and/or other types of forces.
With continuing reference to
1. Substrate Layer 120 is a lens disc with signal tracks. The substrate layer may be a CD, CD-R, DVD, or DVD-R type disc, for example. The substrate 120 may include a reflective layer 142 which can be transmissive or partially reflective as described above in conjunction with
2. Lower channel layer 212 may be formed from an adhesive with fluidic channels 128 formed therein.
3. Chromatographic layer 210 is a disc layer having pass through ports 206 designed such that a chromatographic membrane material 216 may be integrated into the optical bio-disc 110. Chromatographic membranes 216 are preferably placed in or on the pass through ports 206. The membrane and chromatographic layer thickness are preferably identical. If the thickness of the membrane and chromatographic layer is different, then thickness of each can be adjusted by applying multiple layers.
4. Upper channel layer 208 may be formed from an adhesive with fluidic channels formed therein. The patterned fluidic channels overlap with the fluidic channels from the lower channel layer 212 at the pass through ports 206 of the chromatographic layer only, as shown. Thus, the analyte will pass through these fluidic paths by vertically flowing through the membranes only, as shown in
5. The topmost cap portion 116 is a cover disc. The fluidic channels 128 are made to accommodate the test sample, especially when a large analyte volume is required for the assay.
6. The optical bio-disc of the present invention may optionally include a sealing layer (not shown) over the cap portion 116. It covers the vent port 124 and inlet port 122 and prevents contamination of the fluidic circuits 128 and also prevents evaporation of the test sample when loaded into the bio-disc.
Generally, the separation concept is based on having the chromatographic membrane material 216 arranged within the two layers of fluidic path as shown in
By extending this module in series, the analyte can flow through more than two layers of membrane (as shown in
More particular discussion of membranes as implemented on optical bio-discs are provided in the following commonly assigned and co-pending provisional applications: U.S. Provisional App. Ser. No. 60/353,740 entitled “Methods and Apparatus for Separation of Lipoproteins Using Membranes on Optical Bio-Discs” filed Jan. 30, 2002; U.S. Provisional App. Ser. No. 60/353,300 entitled “Methods for Differential Cell Counts Including Leukocytes and Use of Optical Bio-Disc for Performing Same” filed Jan. 31, 2002; U.S. Provisional App. Ser. No. 60/353,948 entitled “Methods for Quantitation and Multiplexing of Receptor Ligand Assay by Use of Ultrathin Biomembranes Including Modified Optical Disc and Drive” filed Jan. 31, 2002; U.S. Provisional App. Ser. No. 60/354,014 entitled “Membrane Assays Implemented On Optical Analysis Disc” filed Jan. 31, 2002; U.S. Provisional App. Ser. No. 60/353,913 entitled “Optical Bio-Disc Membrane Quantification Apparatus and Methods Using Control Lines as Internal Standard” filed Jan. 31, 2002; U.S. Provisional App. Ser. No. 60/353,818 entitled “Methods And Apparatus For Separation Of Blood Using Membranes On Optical Bio-Discs” filed Jan. 31, 2002; U.S. Provisional App. Ser. No. 60/354,319 entitled “Use of Avidin-Biotin Systems for Increase Detection Sensitivity in Membrane Based Assays and Related Optical Analysis Disc” filed Feb. 4, 2002; and U.S. Provisional App. Ser. No. 60/354,379 entitled “Application Methods For Bio-Membrane Assays In Bio-Disc System and Optical Analysis Disc Made According Thereto” filed Feb. 4, 2002. All of these applications are herein incorporated by reference in their entireties. They thus provide background and related disclosure as support hereof as if fully repeated herein.
Additional embodiments, aspects, details, and attributes of the present invention are disclosed in Appendix A and B, appended hereto. These appendices are therefore a part hereof wherein more specifically Appendix A includes pages A1-A38, and Appendix B includes pages B1-B23.
3) Other Implementations of the Current Invention
This invention or different aspects thereof may be readily implemented in, adapted to, or employed in combination with the discs, assays, and systems disclosed in the following commonly assigned and co-pending patent applications: U.S. patent application Ser. No. 09/378,878 entitled “Methods and Apparatus for Analyzing Operational and Non-operational Data Acquired from Optical Discs” filed Aug. 23, 1999; U.S. Provisional Patent Application Ser. No. 60/150,288 entitled “Methods and Apparatus for Optical Disc Data Acquisition Using Physical Synchronization Markers” filed Aug. 23, 1999; U.S. patent application Ser. No. 09/421,870 entitled “Trackable Optical Discs with Concurrently Readable Analyte Material” filed Oct. 26, 1999; U.S. patent application Ser. No. 09/643,106 entitled “Methods and Apparatus for Optical Disc Data Acquisition Using Physical Synchronization Markers” filed Aug. 21, 2000; U.S. patent application Ser. No. 09/999,274 entitled “Optical Biodiscs with Reflective Layers” filed Nov. 15, 2001; U.S. patent application Ser. No. 09/988,728 entitled “Methods and Apparatus for Detecting and Quantifying Lymphocytes with Optical Biodiscs” filed Nov. 16, 2001; U.S. patent application Ser. No. 09/988,850 entitled “Methods and Apparatus for Blood Typing with Optical Bio-discs” filed Nov. 19, 2001; U.S. patent application Ser. No. 09/989,684 entitled “Apparatus and Methods for Separating Agglutinants and Disperse Particles” filed Nov. 20, 2001; U.S. patent application Ser. No. 09/997,741 entitled “Dual Bead Assays Including Optical Biodiscs and Methods Relating Thereto” filed Nov. 27, 2001; U.S. patent application Ser. No. 09/997,895 entitled “Apparatus and Methods for Separating Components of Particulate Suspension” filed Nov. 30, 2001; U.S. patent application Ser. No. 10/005,313 entitled “Optical Discs for Measuring Analytes” filed Dec. 7, 2001; U.S. patent application Ser. No. 10/006,371 entitled “Methods for Detecting Analytes Using Optical Discs and Optical Disc Readers” filed Dec. 10, 2001; U.S. patent application Ser. No. 10/006,620 entitled “Multiple Data Layer Optical Discs for Detecting Analytes” filed Dec. 10, 2001; U.S. patent application Ser. No. 10/006,619 entitled “Optical Disc Assemblies for Performing Assays” filed Dec. 10, 2001; U.S. patent application Ser. No. 10/020,140 entitled “Detection System For Disk-Based Laboratory and Improved Optical Bio-Disc Including Same” filed Dec. 14, 2001; U.S. patent application Ser. No. 10/035,836 entitled “Surface Assembly for Immobilizing DNA Capture Probes and Bead-Based Assay Including Optical Bio-Discs and Methods Relating Thereto” filed Dec. 21, 2001; U.S. patent application Ser. No. 10/038,297 entitled “Dual Bead Assays Including Covalent Linkages for Improved Specificity and Related Optical Analysis Discs” filed Jan. 4, 2002; U.S. patent application Ser. No. 10/043,688 entitled “Optical Disc Analysis System Including Related Methods for Biological and Medical Imaging” filed Jan. 10, 2002; U.S. Provisional Application Ser. No. 60/348,767 entitled “Optical Disc Analysis System Including Related Signal Processing Methods and Software” filed Jan. 14, 2002 U.S. patent application Ser. No. 10/086,941 entitled “Methods for DNA Conjugation Onto Solid Phase Including Related Optical Biodiscs and Disc Drive Systems” filed Feb. 26, 2002; U.S. patent application Ser. No. 10/087,549 entitled “Methods for Decreasing Non-Specific Binding of Beads in Dual Bead Assays Including Related Optical Biodiscs and Disc Drive Systems” filed Feb. 28, 2002; U.S. patent application Ser. No. 10/099,256 entitled “Dual Bead Assays Using Cleavable Spacers and/or Ligation to Improve Specificity and Sensitivity Including Related Methods and Apparatus” filed Mar. 14, 2002; U.S. patent application Ser. No. 10/099,266 entitled “Use of Restriction Enzymes and Other Chemical Methods to Decrease Non-Specific Binding in Dual Bead Assays and Related Bio-Discs, Methods, and System Apparatus for Detecting Medical Targets” also filed Mar. 14, 2002; U.S. patent application Ser. No. 10/121,281 entitled “Multi-Parameter Assays Including Analysis Discs and Methods Relating Thereto” filed Apr. 11, 2002; U.S. patent application Ser. No. 10/150,575 entitled “Variable Sampling Control for Rendering Pixelization of Analysis Results in a Bio-Disc Assembly and Apparatus Relating Thereto” filed May 16, 2002; U.S. patent application Ser. No. 10/150,702 entitled “Surface Assembly For Immobilizing DNA Capture Probes in Genetic Assays Using Enzymatic Reactions to Generate Signals in Optical Bio-Discs and Methods Relating Thereto” filed May 16, 2002; U.S. patent application Ser. No. 10/194,418 entitled “Optical Disc System and Related Detecting and Decoding Methods for Analysis of Microscopic Structures” filed Jul. 12, 2002; U.S. patent application Ser. No. 10/194,396 entitled “Multi-Purpose Optical Analysis Disc for Conducting Assays and Various Reporting Agents for Use Therewith” also filed Jul. 12, 2002; U.S. patent application Ser. No. 10/199,973 entitled “Transmissive Optical Disc Assemblies for Performing Physical Measurements and Methods Relating Thereto” filed Jul. 19, 2002; U.S. patent application Ser. No. 10/201,591 entitled “Optical Analysis Disc and Related Drive Assembly for Performing Interactive Centrifugation” filed Jul. 22, 2002; U.S. patent application Ser. No. 10/205,011 entitled “Method and Apparatus for Bonded Fluidic Circuit for Optical Bio-Disc” filed Jul. 24, 2002; U.S. patent application Ser. No. 10/205,005 entitled “Magnetic Assisted Detection of Magnetic Beads Using Optical Disc Drives” also filed Jul. 24, 2002; U.S. patent application Ser. No. 10/230,959 entitled “Methods for Qualitative and Quantitative Analysis of Cells and Related Optical Bio-Disc Systems” filed Aug. 29, 2002; U.S. patent application Ser. No. 10/233,322 entitled “Capture Layer Assemblies for Cellular Assays Including Related Optical Analysis Discs and Methods” filed Aug. 30, 2002; U.S. patent application Ser. No. 10/236,857 entitled “Nuclear Morphology Based Identification and Quantification of White Blood Cell Types Using Optical Bio-Disc Systems” filed Sep. 6, 2002; U.S. patent application Ser. No. 10/241,512 entitled “Methods for Differential Cell Counts Including Related Apparatus and Software for Performing Same” filed Sep. 11, 2002; U.S. patent application Ser. No. 10/279,677 entitled “Segmented Area Detector for Biodrive and Methods Relating Thereto” filed Oct. 24, 2002; U.S. patent application Ser. No. 10/293,214 entitled “Optical Bio-Discs and Fluidic Circuits for Analysis of Cells and Methods Relating Thereto” filed on Nov. 13, 2002; U.S. patent application Ser. No. 10/298,263 entitled “Methods and Apparatus for Blood Typing with Optical Bio-Discs” filed on Nov. 15, 2002; U.S. patent application Ser. No. 10/307,263 entitled “Magneto-Optical Bio-Discs and Systems Including Related Methods” filed Nov. 27, 2002; U.S. patent application Ser. No. 10/341,326 entitled “Method and Apparatus for Visualizing Data” filed Jan. 13, 2003; U.S. patent application Ser. No. 10/345,122 entitled “Methods and Apparatus for Extracting Data From an Optical Analysis Disc” filed on Jan. 14, 2003; U.S. patent application Ser. No. 10/347,155 entitled “Optical Discs Including Equi-Radial and/or Spiral Analysis Zones and Related Disc Drive Systems and Methods” filed on Jan. 15, 2003; U.S. patent application Ser. No. 10/347,119 entitled “Bio-Safe Dispenser and Optical Analysis Disc Assembly” filed Jan. 17, 2003; U.S. patent application Ser. No. 10/348,049 entitled “Multi-Purpose Optical Analysis Disc for Conducting Assays and Related Methods for Attaching Capture Agents” filed on Jan. 21, 2003; U.S. patent application Ser. No. 10/348,196 entitled “Processes for Manufacturing Optical Analysis Discs with Molded Microfluidic Structures and Discs Made According Thereto” filed on Jan. 21, 2003; U.S. patent application Ser. No. 10/351,604 entitled “Methods for Triggering Through Disc Grooves and Related Optical Analysis Discs and System” filed on Jan. 23, 2003; U.S. patent application Ser. No. 10/351,280 entitled “Bio-Safety Features for Optical Analysis Discs and Disc System Including Same” filed on Jan. 23, 2003; U.S. patent application Ser. No. 10/351,244 entitled “Manufacturing Processes for Making Optical Analysis Discs Including Successive Patterning Operations and Optical Discs Thereby Manufactured” filed on Jan. 24, 2003; U.S. patent application Ser. No. 10/353,777 entitled “Processes for Manufacturing Optical Analysis Discs with Molded Microfluidic Structures and Discs Made According Thereto” filed on Jan. 27, 2003; U.S. patent application Ser. No. 10/353,839 entitled “Method and Apparatus for Logical Triggering” filed on Jan. 28, 2003; and U.S. patent application Ser. No. 10/356,666 entitled “Methods For Synthesis of Bio-Active Nanoparticles and Nanocapsules For Use in Optical Bio-Disc Assays and Disc Assembly Including Same” filed Jan. 30, 2003. All of these applications are herein incorporated by reference in their entireties. They thus provide background and related disclosure as support hereof as if fully repeated herein.
All patents, provisional applications, patent applications, technical specifications, and other publications mentioned in this specification are incorporated herein in their entireties by reference.
While this invention has been described in detail with reference to certain preferred embodiments, it should be appreciated that the present invention is not limited to those precise embodiments. Rather, in view of the present optical bio-system disclosure that describes the current best mode for practicing the invention, many modifications and variations would present themselves to those of skill in the art without departing from the scope and spirit of this invention. The scope of the invention is, therefore, indicated by the following claims rather than by the foregoing description. All changes, modifications, and variations coming within the meaning and range of equivalency of the claims are to be considered within their scope.
Furthermore, those skilled in the art will recognize, or be able to ascertain, using no more than routine experimentation, many equivalents to the specific embodiments of the invention described herein. Such equivalents are also intended to be encompassed by the following claims.
This application claims priority to U.S. Provisional Application No. 60/449,192, filed Feb. 21, 2003, which is hereby incorporated by reference in its entirety, including FIGS. 1-22C.
Number | Date | Country | |
---|---|---|---|
60449192 | Feb 2003 | US |